Integrating software development and evidence generation helps digital heath firms get more value from clinical research -- and get to market faster.
Today’s digital health firms creating next-generation software as a medical device products regularly confront a conflict between rapid software development life cycles and methodical evidence generation procedures. SaMD products must be evidence-based and clinically validated before patients can use them. This scrutiny is necessary to ensure products are safe and effective, but it presents challenges to digital health firms more familiar with software development than the rigors of clinical trials and regulatory approval.
Download this white paper to discover how integrated evidence planning – aligning evidence generation, product development workflows, and long-term business objectives – can help firms get the most out of the valuable but scarce resources that are required to conduct proper, evidence-based clinical research.
Offered Free by: ZS Associates
See All Resources from: ZS Associates
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.